Scarica l'app Stockscreener
6.57
4.29%
0.27
Dopo l'orario di chiusura:
6.49
-0.08
-1.22%
Nutriband Inc Borsa (NTRB) Ultime notizie
After €40m losses, Nutriband faces crucial approval phase as its CEO pitches for the Áras - The Currency
Why Nutriband Inc. stock attracts strong analyst attentionMarket Growth Summary & Safe Swing Trade Setups - beatles.ru
Presidential hopeful Gareth Sheridan's Nutriband was fined by US government - MSN
Gareth Sheridan fined in 2018 for making misleading statements about his company - The Irish Times
Businessman Gareth Sheridan's wife Heidi thought their first meeting was 'absurd' - MSN
Seán Gallagher quit Nutriband after firm decided to change chairman, says Gareth Sheridan - The Irish Times
Nutriband Inc. Equity Warrant Building a Base Near Support [Market Sentiment Review]Fast Momentum Stock Entry Tips - beatles.ru
Nutriband Inc. CEO Temporarily Steps Down to Pursue Irish Presidential Candidacy - citybuzz -
Nutriband (NASDAQ: NTRB) CEO Steps Aside Temporarily To Run For Irish Presidency - Barchart.com
Nutriband (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency - The Globe and Mail
Nutriband Inc. shares fall 2.37% premarket after CEO steps aside for election. - AInvest
Nutriband CEO to Step Aside Temporarily to Seek Nomination in Irish Presidential Election - MarketScreener
Navigating Leadership Shifts and Regulatory Hurdles: Nutriband's Path to AVERSA Fentanyl Commercialization - AInvest
Nutriband Inc. CEO Gareth Sheridan Takes Leave to Run for Irish Presidential Election; Serguei Melnik Appointed Interim CEO - Quiver Quantitative
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election - GlobeNewswire
Nutriband CEO Pursues Irish Presidency: What This Bold Move Means for Company Future - Stock Titan
Apple's Silence on AI Glasses and Deals: Strategic Genius or Warning Sign for Investors? - The Globe and Mail
Multi-millionaire pharma tycoon Gareth Sheridan (35) launches bid for Irish presidency - The Irish Independent
Multi-millionaire businessman Gareth Sheridan announces bid for presidency - MSN
Nutriband Inc. Company Revenue and Profit Trends: A Deep DiveTechnical Long-Term Outlook and Recap Guide - Newser
What technical models suggest about Nutriband Inc. Equity Warrant’s comebackShort Term Momentum Based Trading Strategy - Newser
Applying big data sentiment scoring on Nutriband Inc. Equity WarrantTrade Safety Report with Pattern Insights - Newser
Price Channel Expanding on Nutriband Inc.’s ChartStep-by-Step Stock Investment Guide Gains Popularity - beatles.ru
Why Nutriband Inc. Equity Warrant stock attracts strong analyst attentionFree Real Time Stock Movement Analysis - Newser
Nutriband Shares Climb After FDA Grants Meeting for Fentanyl Patch - MSN
What institutional flow reveals about Nutriband Inc.Risk Aware Trading Ideas with Alert Levels - Newser
Detecting support and resistance levels for Nutriband Inc. Equity WarrantStock Price Prediction Using AI Tools - Newser
Visualizing Nutriband Inc. Equity Warrant stock with heatmapsStock Trading Session Highlights and Summary - Newser
Nutriband Inc. Advances Toward FDA Approval for AVERSA(TM) Fentanyl Abuse-Deterrent Patch - citybuzz -
Nutriband Inc. shares fall 3.07% after-hours following FDA meeting request for Aversa Fentanyl. - AInvest
Nutriband up after FDA grants meeting for firm's fentanyl patch - TradingView
Fda Grants Nutriband Meeting Request for Aversa?? Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener
Nutriband Inc. Announces FDA Meeting for AVERSA™ FENTANYL to Discuss CMC Plans Through Commercialization - Quiver Quantitative
FDA to meet with Nutriband on abuse-deterrent fentanyl patch By Investing.com - Investing.com Australia
Nutriband stock rises after FDA grants meeting for fentanyl patch By Investing.com - Investing.com India
FDA to meet with Nutriband on abuse-deterrent fentanyl patch - Investing.com
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener
Revolutionary Abuse-Deterrent Fentanyl Patch Advances Toward FDA Review, $200M Market Potential - Stock Titan
Nutriband Completes Stock Dividend of Preferred Shares - TipRanks
Nutriband (NTRB) issues 3.0M Series A Preferred via stock dividend | NTRBW SEC FilingForm 8-K - Stock Titan
Exit strategy if you’re trapped in Nutriband Inc.Free Market Entry and Exit Point Tips - Newser
Nutriband Inc. Pioneers Abuse-Deterrent Technology for Fentanyl Delivery - citybuzz -
Nutriband (NASDAQ: NTRB) Aligns Shareholder Value With FDA Milestone - Barchart.com
Nutriband (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone - The Globe and Mail
Nutriband CEO Gareth Sheridan: “The economy is booming, but that’s a punch to the gut – when we’re a top 5 performer in every major index but our own people can’t afford to live here - Hotpress
Price action breakdown for Nutriband Inc. Equity WarrantFree Daily Volume Spike Trading Signals - Newser
What makes Nutriband Inc. Equity Warrant stock price move sharplyFree Consistent Income Focused Trade List - Newser
Is Nutriband Inc. Equity Warrant stock reversal real or fakeShort Term Profit Strategy with Entry Cues - Newser
Can Nutriband Inc. Equity Warrant recover in the next quarterVolume Confirmed Setup with Entry Confidence - Newser
Nutriband Inc. Equity Warrant Facing Inflection Point in Trend AnalysisTrade Scanner With Buy Zone Alerts Flagged - beatles.ru
Sentiment Tools Show Shift in Trader Mood on Nutriband Inc.Fast Gaining Stock Screener Reports Released - beatles.ru
What analysts say about Nutriband Inc. Equity Warrant stockCapitalize on market trends with expert guidance - Jammu Links News
Is it the right time to buy Nutriband Inc. stockMarket-leading growth rates - Jammu Links News
Nutriband Inc. Equity Warrant Stock Analysis and ForecastJaw-dropping returns - Jammu Links News
Why is Nutriband Inc. stock attracting strong analyst attentionBuild wealth steadily with proven strategies - Jammu Links News
What are analysts’ price targets for Nutriband Inc. in the next 12 monthsHigh-impact stock picks - Jammu Links News
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):